Knowledge | NT Screening During Pregnancy: Assessing the Risk of Down Syndrome and Other Genetic Conditions
During pregnancy, a doctor may recommend an NT (nuchal translucency) scan. This noninvasive ultrasound screening primarily assesses the fetus's risk of Down syndrome and other genetic conditions. NT screening is usually performed between 11 and 14 weeks of pregnancy and provides important information for prenatal care.
What Is an NT Scan?
An NT scan uses ultrasound to measure the thickness of the nuchal translucency, a fluid-filled space under the skin at the back of the fetal neck, to assess the risk of genetic conditions. It may be combined with blood tests that measure specific hormones and proteins:
Free beta-human chorionic gonadotropin (β-hCG)
Pregnancy-associated plasma protein A (PAPP-A)
Alpha-fetoprotein (AFP)
Abnormal levels may indicate an increased risk of a genetic condition. Combining an NT scan with blood tests is known as first-trimester combined screening.
Conditions Assessed by NT Screening
An abnormal increase in fluid at the back of the fetal neck may be associated with:
Down syndrome (trisomy 21): a genetic condition caused by an extra chromosome 21 that can result in intellectual and physical developmental disabilities, congenital anomalies, and health problems.
Trisomy 13 and trisomy 18: an extra chromosome 13 or 18 can cause severe congenital anomalies and intellectual disability and often leads to early death.
Turner syndrome: caused by the complete or partial absence of an X chromosome, this condition affects fetuses with an X sex chromosome and can cause growth problems and heart or ovarian abnormalities.
Congenital heart disease: this can cause abnormal blood flow through the heart and may be life-threatening in some cases.
NT screening cannot diagnose these conditions; it only estimates whether the risk may be higher or lower.
The NT Scan Procedure
An NT scan is a routine ultrasound. A full bladder is required, and pregnant women are usually asked to drink 2 to 3 cups of water one hour before the scan and avoid urinating.
During the scan, the patient lies on an examination table. The sonographer applies conductive gel to the abdomen and moves an ultrasound transducer over it to obtain images. A radiologist then reviews the images and sends the findings to the treating doctor.
Safety of NT Screening
An NT scan is safe and noninvasive, with no known risks. Mild pressure from the transducer on the abdomen is normal.
Is NT Screening Necessary?
NT screening is optional. It can provide preliminary results early in pregnancy and help prospective parents plan. A pregnant woman may also decline the scan, particularly if the result would not change pregnancy management.
Understanding NT Results
Nuchal translucency thickness changes as the fetus grows. The normal range is up to 2 mm at 11 weeks and up to 2.8 mm at 13 weeks and 6 days. Measurements above this range may indicate a higher risk of a genetic condition.
A doctor evaluates the measurement together with maternal age and blood test results. Combined NT and blood screening can identify up to 85% of genetic conditions, but about 5% of results may be false positives.
Next Steps After an Abnormal Result
If an NT result is abnormal, the doctor may recommend additional tests, including:
Chorionic villus sampling: removing placental tissue for analysis.
Amniocentesis: testing a sample of amniotic fluid for fetal chromosomal conditions.
Cell-free DNA prenatal screening (cfDNA): analyzing fetal DNA in maternal blood.
Some of these tests may carry a risk of miscarriage. The doctor will explain the risks and benefits to help prospective parents decide.
Summary
An NT scan is a safe, routine, optional ultrasound screening that helps estimate the likelihood of Down syndrome and other genetic conditions. Prospective parents can decide whether to have the screening based on their individual needs.
Knowledge | NT Screening During Pregnancy: Assessing the Risk of Down Syndrome and Other Genetic Conditions
Knowledge | NT Screening During Pregnancy: Assessing the Risk of Down Syndrome and Other Genetic Conditions
During pregnancy, a doctor may recommend an NT (nuchal translucency) scan. This noninvasive ultrasound screening primarily assesses the fetus's risk of Down syndrome and other genetic conditions. NT screening is usually performed between 11 and 14 weeks of pregnancy and provides important information for prenatal care.
What Is an NT Scan?
An NT scan uses ultrasound to measure the thickness of the nuchal translucency, a fluid-filled space under the skin at the back of the fetal neck, to assess the risk of genetic conditions. It may be combined with blood tests that measure specific hormones and proteins:
Free beta-human chorionic gonadotropin (β-hCG)
Pregnancy-associated plasma protein A (PAPP-A)
Alpha-fetoprotein (AFP)
Abnormal levels may indicate an increased risk of a genetic condition. Combining an NT scan with blood tests is known as first-trimester combined screening.
Conditions Assessed by NT Screening
An abnormal increase in fluid at the back of the fetal neck may be associated with:
Down syndrome (trisomy 21): a genetic condition caused by an extra chromosome 21 that can result in intellectual and physical developmental disabilities, congenital anomalies, and health problems.
Trisomy 13 and trisomy 18: an extra chromosome 13 or 18 can cause severe congenital anomalies and intellectual disability and often leads to early death.
Turner syndrome: caused by the complete or partial absence of an X chromosome, this condition affects fetuses with an X sex chromosome and can cause growth problems and heart or ovarian abnormalities.
Congenital heart disease: this can cause abnormal blood flow through the heart and may be life-threatening in some cases.
NT screening cannot diagnose these conditions; it only estimates whether the risk may be higher or lower.
The NT Scan Procedure
An NT scan is a routine ultrasound. A full bladder is required, and pregnant women are usually asked to drink 2 to 3 cups of water one hour before the scan and avoid urinating.
During the scan, the patient lies on an examination table. The sonographer applies conductive gel to the abdomen and moves an ultrasound transducer over it to obtain images. A radiologist then reviews the images and sends the findings to the treating doctor.
Safety of NT Screening
An NT scan is safe and noninvasive, with no known risks. Mild pressure from the transducer on the abdomen is normal.
Is NT Screening Necessary?
NT screening is optional. It can provide preliminary results early in pregnancy and help prospective parents plan. A pregnant woman may also decline the scan, particularly if the result would not change pregnancy management.
Understanding NT Results
Nuchal translucency thickness changes as the fetus grows. The normal range is up to 2 mm at 11 weeks and up to 2.8 mm at 13 weeks and 6 days. Measurements above this range may indicate a higher risk of a genetic condition.
A doctor evaluates the measurement together with maternal age and blood test results. Combined NT and blood screening can identify up to 85% of genetic conditions, but about 5% of results may be false positives.
Next Steps After an Abnormal Result
If an NT result is abnormal, the doctor may recommend additional tests, including:
Chorionic villus sampling: removing placental tissue for analysis.
Amniocentesis: testing a sample of amniotic fluid for fetal chromosomal conditions.
Cell-free DNA prenatal screening (cfDNA): analyzing fetal DNA in maternal blood.
Some of these tests may carry a risk of miscarriage. The doctor will explain the risks and benefits to help prospective parents decide.
Summary
An NT scan is a safe, routine, optional ultrasound screening that helps estimate the likelihood of Down syndrome and other genetic conditions. Prospective parents can decide whether to have the screening based on their individual needs.
Source:
Collected online